476 Serum Proteomic Classification in Refractory...

European Journal of Cancer 2012 / 11 Vol. 48

476 Serum Proteomic Classification in Refractory Non-small-cell Lung Cancer Treated with Erlotinib +/− Pazopanib in a Randomized Placebo-controlled Phase II Study

Spigel, D.R., Burris, H.A., Greco, F.A., Lipman, A.J., Waterhouse, D.M., Daniel, D.B., Ma, Z., Arkenau, H.T., Grigorieva, J., Hainsworth, J.D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
48
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(12)72274-8
Date:
November, 2012
File:
PDF, 73 KB
english, 2012
Conversion to is in progress
Conversion to is failed